Atherectomy Devices Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
Report ID: GMI2769
Atherectomy Devices Market size is expected to grow significantly from 2019 to 2025.
Atherectomy devices market is estimated to witness lucrative growth over the coming years owing to rising prevalence of cardiovascular disease. According to WHO, nearly 17.9 million died of cardiovascular disease that accounts for 31% of death worldwide. Atherectomy devices are effective in treating both peripheral and coronary artery disease widely used to restore blood flow and promote wellbeing in patients. Aforementioned factor coupled with increasing geriatric population susceptible to several chronic conditions will stimulate industry growth.
Increasing adoption of advanced atherectomy procedures involving minimally invasive techniques will boost the demand for atherectomy devices in forthcoming future. Furthermore, favorable regulatory scenario for medical devices motivates key industry player to introduce novel products. For instance, companies have launched upgraded atherectomy system that combines benefits of existing atherectomy system and offer unique solution. However, lack of skilled medical professionals and postoperative complication may hinder industry growth.
Directional atherectomy devices segment will witness significant growth in forthcoming years owing to advantages offered by it over conventional atherectomy devices. Directional atherectomy devices involves lower treatment cost and improved efficiency. Furthermore, introduction of advanced atherectomy devices proves beneficial for the industry growth. For instance, Medtronic has launched HawkOne directional atherectomy system that facilitates removal of plaque and restore blood flow. Thus, introduction of advanced atherectomy devices by key players will positively influence the segmental growth.
Peripheral vascular diseases segment will experience lucrative growth throughout the forecast period. Increasing prevalence of peripheral vascular diseases due lifestyle changes will boost the demand for atherectomy devices. Peripheral vascular disease caused due to blockage of blood vessels results in stroke, kidney disease or aneurysm if left untreated. Hence, atherectomy devices are gaining immense popularity among clinicians to promote quicker and minimal invasive procedures that augments the business growth.
Hospital segment will witness robust growth in forthcoming years owing to increasing patient preference towards atherectomy procedures as they are convenient than invasive operational procedures. In addition, elderly population base susceptible to several critical diseases often prefer atherectomy procedures in hospitals that are well-equipped with advanced medical devices. Aforementioned factors will elevate the segmental growth.
North America is projected to witness dominant position in atherectomy devices market during forecasted period owing to increasing adoption of advanced atherectomy procedures involving minimal invasive technique to treat critical disease. Furthermore, presence of huge geriatric population that are more susceptible to peripheral artery diseases (PAD). This scenario proves beneficial for the industry growth as it surges the demand for technologically advanced atherectomy devices thereby, fostering regional market growth.
Some of the major players operating in Atherectomy Devices market include Avinger, Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, R. Bard, Cardinal Health, Medtronic Plc, Philips.Market players are adopting strategies such as product launches, partnerships and acquisitions to garner higher market share and sustain market competition. For instance, Boston Scientific Corporation has launched Jetstream atherectomy system that enables treatment of multiple morphologies, such as plaque, calcium commonly found in total occlusions as well minimizes the risk of distal embolization. Introduction of such advanced products will boost company’s growth.
Atherectomy Devices Market By Technology, 2014-2025 (USD Million)
- Directional atherectomy devices
- Orbital atherectomy devices
- Laser atherectomy devices
- Rotational atherectomy devices
Atherectomy Devices Market By Disease Indication, 2014-2025 (USD Million)
- Cardiovascular diseases
- Neurovascular diseases
- Peripheral Vascular diseases
Atherectomy Devices Market By End-user, 2014-2025 (USD Million)
- Ambulatory surgical centers (ASCs)
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- B.Braun Melsungen AG
- Boston Scientific Corporation
- R. Bard
- Cardinal Health
- Medtronic Plc
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.